Kumar Prafull Chandra

2474-P: Comparable Hepatic Benefits with Differential Effects on Triglycerides and Glycemic Control: A 24-Week Prospective Study

DINESH KUMAR, Harshita Lachhwani, MUKULESH GUPTA, Kumar Prafull Chandra et autres

1659-P: Early Metabolic and Hepatic Benefits of Tirzepatide in Indian Adults with Type 2 Diabetes: Insights from Real-World Practice

DINESH KUMAR, Kumar Prafull Chandra, RAJIV AWASTHI, MUKULESH GUPTA et autres

A Study to Understand the Usage of Glucose Meter in the Management of Type 2 Diabetes Mellitus in Northern India: A Cross-sectional Study

Prabhat Agrawal, Anuj Maheshwari, Ajoy Tewari, Narsingh Verma et autres

in, pk (code pays fourni par la source)

A multicentre survey of liver fibrosis burden in type 2 diabetes in India: the DiaFib-Liver Study

Ashish Kumar, Jayant Panda, Prabhat Agrawal, Sunil Gupta et autres

in, ca (code pays fourni par la source)

Early Diabetes Remission Following Tirzepatide-Based Combination Therapy in a Young Indian Adult with Recent-Onset Type 2 Diabetes: A Case Report

Tanuj Diyora, Kumar Prafull Chandra

in (code pays fourni par la source)

Real-World Evidence of Tirzepatide in Indian Adults With Type 2 Diabetes: Significant Early Glycemic and Cardiometabolic Benefits

Kumar Prafull Chandra, Mukulesh Gupta, Rajiv Awasthi, Arunkumar Pande et autres

au, us, in (code pays fourni par la source)

A Prospective Real-world Study to Assess Safety, Tolerability, and Effectiveness of Imeglimin among People with Type 2 Diabetes Mellitus Who are Intolerant to Metformin (PRISM Study)

Prabhat Kumar Agrawal, Ketan K Mehta, Abhisekh Raha, Rajesh Agarwal et autres

in, us (code pays fourni par la source)

Easy Fatigability! What is the Cause?

Arun Kumar Pande, Kumar Prafull Chandra, Dinesh Kumar

in (code pays fourni par la source)

Efficacy of saroglitazar magnesium in MASLD patients: A prospective real-world assessment of liver and metabolic health

Harshita Lachhwani, Manoj Kumar Gupta, Kumar Prafull Chandra, R. Awasthi et autres

au, in (code pays fourni par la source)

Predictors of Dual Phosphodiesterase Type 5 Inhibitor Therapy in Persons With Erectile Dysfunction and Diabetes

Arun K. Pande, Ashish Kumar Jha, Kumar Prafull Chandra, Anurag Pathak et autres

in, au (code pays fourni par la source)

Inappropriate Use of Serum Osmolarity Formulas in the Measurement of Urine Osmolality

Arun K. Pande, Ajay Aggarwal, Kumar Prafull Chandra

in (code pays fourni par la source)

A prospective, open-label, randomized, comparative clinical trial to assess the efficacy of NASO B12 or oral B12 supplementation along with standard of care in the treatment of anemia in women of reproductive age

Mukulesh Gupta, Dinesh Kumar, Kumar Prafull Chandra

in, au (code pays fourni par la source)